[HTML][HTML] Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection

FJ Palella Jr, KM Delaney, AC Moorman… - … England Journal of …, 1998 - Mass Medical Soc
Background and Methods National surveillance data show recent, marked reductions in
morbidity and mortality associated with the acquired immunodeficiency syndrome (AIDS). To …

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study

FJ Palella Jr, RK Baker, AC Moorman… - JAIDS Journal of …, 2006 - journals.lww.com
Background: AIDS-related death and disease rates have declined in the highly active
antiretroviral therapy (HAART) era and remain low; however, current causes of death in HAART-…

Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003

…, PS Sullivan, RM Novak, AC Moorman… - Annals of internal …, 2008 - acpjournals.org
Background: Persons who are HIV-infected may be at higher risk for certain types of cancer
than the general population. Objective: To compare cancer incidence among HIV-infected …

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

SD Holmberg, AC Moorman, JM Williamson, TC Tong… - The Lancet, 2002 - thelancet.com
Protease inhibitors for treatment of HIV-1 have been linked with increased risk of hyperlipidaemia
and hyperglycaemia. In a cohort of 5672 outpatients with HIV-1 seen at nine US HIV …

Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata

…, M Deloria-Knoll, JS Chmiel, AC Moorman… - Annals of internal …, 2003 - acpjournals.org
Background: Optimal timing of antiretroviral therapy (ART) initiation for HIV-infected persons
remains unclear. Objective: To assess survival benefit of initiating ART at different CD4+ cell …

Clinical assessment of HIV-associated lipodystrophy in an ambulatory population

KA Lichtenstein, DJ Ward, AC Moorman, KM Delaney… - Aids, 2001 - journals.lww.com
Objective To identify clinical factors associated with prevalence of fat atrophy (lipoatrophy)
and fat accumulation (lipoaccumulation) in HIV-1 infected patients. Design Evaluation of HIV-…

[HTML][HTML] Hepatitis C in the United States

SD Holmberg, PR Spradling, AC Moorman… - The New England …, 2013 - ncbi.nlm.nih.gov
Care for hepatitis C is evolving rapidly, with increasingly effective and better-tolerated antiviral
therapies being evaluated and approved for use. It’s clear, however, that not everyone …

Nonhospital health care–associated hepatitis B and C virus transmission: United States, 1998–2008

ND Thompson, JF Perz, AC Moorman… - Annals of Internal …, 2009 - acpjournals.org
In the United States, transmission of hepatitis B virus (HBV) and hepatitis C virus (HCV) from
health care exposures has been considered uncommon. However, a review of outbreak …

Transmission of blood-borne pathogens in US dental health care settings: 2016 update

…, SK Gray, JA Harte, VA Robison, AC Moorman… - The Journal of the …, 2016 - Elsevier
Background During the past decade, investigators have reported transmissions of blood-borne
pathogens (BBPs) in dental settings. In this article, the authors describe these …

Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort

…, LB Rupp, LE Lamerato, AC Moorman… - Clinical infectious …, 2013 - academic.oup.com
Background. Liver biopsy remains critical for staging liver disease in hepatitis C virus (HCV)–infected
persons, but is a bottleneck to evaluation, follow-up, and treatment of HCV. Our …